CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 426184-426455 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T13249","span":{"begin":0,"end":271},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Intracisternal injection of the lymphotoxin-beta receptor-Ig fusion protein which blocks the action of lymphotoxin alpha/beta, a key cytokine in lymphoid organ development, either delayed or completely suppressed EAE relapses, and reduced B-cell proliferation in the CNS."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T313","span":{"begin":0,"end":271},"obj":"Sentence"}],"text":"Intracisternal injection of the lymphotoxin-beta receptor-Ig fusion protein which blocks the action of lymphotoxin alpha/beta, a key cytokine in lymphoid organ development, either delayed or completely suppressed EAE relapses, and reduced B-cell proliferation in the CNS."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T845","span":{"begin":213,"end":216},"obj":"Phenotype"}],"attributes":[{"id":"A845","pred":"hp_id","subj":"T845","obj":"http://purl.obolibrary.org/obo/HP_0002383"}],"text":"Intracisternal injection of the lymphotoxin-beta receptor-Ig fusion protein which blocks the action of lymphotoxin alpha/beta, a key cytokine in lymphoid organ development, either delayed or completely suppressed EAE relapses, and reduced B-cell proliferation in the CNS."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1427","span":{"begin":154,"end":159},"obj":"Body_part"},{"id":"T1428","span":{"begin":267,"end":270},"obj":"Body_part"}],"attributes":[{"id":"A1427","pred":"uberon_id","subj":"T1427","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"},{"id":"A1428","pred":"uberon_id","subj":"T1428","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"}],"text":"Intracisternal injection of the lymphotoxin-beta receptor-Ig fusion protein which blocks the action of lymphotoxin alpha/beta, a key cytokine in lymphoid organ development, either delayed or completely suppressed EAE relapses, and reduced B-cell proliferation in the CNS."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2901","span":{"begin":213,"end":216},"obj":"Disease"},{"id":"T2871","span":{"begin":213,"end":216},"obj":"Disease"}],"attributes":[{"id":"A2901","pred":"mondo_id","subj":"T2901","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A2902","pred":"mondo_id","subj":"T2901","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A2903","pred":"mondo_id","subj":"T2901","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A79546","pred":"mondo_id","subj":"T2871","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A39056","pred":"mondo_id","subj":"T2871","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A39760","pred":"mondo_id","subj":"T2871","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"}],"text":"Intracisternal injection of the lymphotoxin-beta receptor-Ig fusion protein which blocks the action of lymphotoxin alpha/beta, a key cytokine in lymphoid organ development, either delayed or completely suppressed EAE relapses, and reduced B-cell proliferation in the CNS."}